Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
Age
18–64
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Attended the previous Phase IIb (core) study
Improved during the core study
No safety issues during the core study
You may not be if
Discontinued the core study
Pregnant or nursing (lactating) women
Clareo Health | A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia
